NVO20250919C40
NVO Sep 19 2025 40.00 Call (NVO250919C00040000)
option OPRA

Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.